Bone Metastases From Solid Tumors Clinical Trials in Pittsburgh, Pennsylvania

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases